Literature DB >> 23625059

Purification and characterization of neurotoxin complex from a dual toxin gene containing Clostridium Botulinum Strain PS-5.

Ajay K Singh1, Amita Sachdeva, Jeffrey A Degrasse, Timothy R Croley, Larry H Stanker, David Hodge, Shashi K Sharma.   

Abstract

Botulinum neurotoxins are produced as a toxin complex (TC) which consists of neurotoxin (NT) and neurotoxin associated proteins. The characterization of NT in its native state is an essential step for developing diagnostics and therapeutic countermeasures against botulism. The presence of NT genes was validated by PCR amplification of toxin specific fragments from genomic DNA of Clostridium botulinum strain PS-5 which indicated the presence of both serotype A and B genes on PS-5 genome. Further, TC was purified and characterized by Western blotting, Digoxin-enzyme linked immunosorbent assay, endopeptidase activity assay, and Liquid chromatography-Mass spectrometry. The data showed the presence of serotype A specific neurotoxin. Based on the analysis of neurotoxin genes and characterization of TC, PS-5 strain appears as a serotype A (B) strain of C. botulinum which produces only serotype A specific TC in the cell culture medium.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23625059     DOI: 10.1007/s10930-013-9486-1

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  40 in total

1.  Modulation of botulinum toxin-induced changes in neuromuscular function with antibodies directed against recombinant polypeptides or fragments.

Authors:  S G Joshi; M Elias; A Singh; F H Al-Saleem; D Ancharski; Z Nasser; T Takahashi; L L Simpson
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

Review 2.  Bioterriorism: from threat to reality.

Authors:  Ronald M Atlas
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

Review 3.  Botulinum neurotoxin: where are we with detection technologies?

Authors:  Ajay K Singh; Larry H Stanker; Shashi K Sharma
Journal:  Crit Rev Microbiol       Date:  2012-06-08       Impact factor: 7.624

4.  Identical novel A5(B3') botulinum neurotoxin gene arrangements isolated from widely disparate geographical and patient sources suggest their independent origins.

Authors:  Nir Dover; Jason R Barash; Stephen S Arnon
Journal:  J Clin Microbiol       Date:  2010-05       Impact factor: 5.948

5.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

6.  The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption.

Authors:  Takuhiro Matsumura; Yingji Jin; Yuko Kabumoto; Yuki Takegahara; Keiji Oguma; Wayne I Lencer; Yukako Fujinaga
Journal:  Cell Microbiol       Date:  2007-09-14       Impact factor: 3.715

7.  Flagellin diversity in Clostridium botulinum groups I and II: a new strategy for strain identification.

Authors:  Catherine J Paul; Susan M Twine; Kevin J Tam; James A Mullen; John F Kelly; John W Austin; Susan M Logan
Journal:  Appl Environ Microbiol       Date:  2007-03-09       Impact factor: 4.792

8.  The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin.

Authors:  Yukako Fujinaga; Kaoru Inoue; Sadahiro Watanabe; Kenji Yokota; Yoshikazu Hirai; Eiko Nagamachi; Keiji Oguma
Journal:  Microbiology (Reading)       Date:  1997-12       Impact factor: 2.777

9.  Oral toxicities of Clostridium botulinum toxins in response to molecular size.

Authors:  I Ohishi; S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

10.  Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.

Authors:  Shashi K Sharma; Joseph L Ferreira; Brian S Eblen; Richard C Whiting
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.